Envista Holdings Intrinsic Value Calculation – ENVISTA HOLDINGS Reports Q2 FY2023 Earnings Results on August 2 2023

🌥️Earnings Overview

On August 2 2023, ENVISTA HOLDINGS ($NYSE:NVST) reported its second quarter earnings results for the period ending June 30 2023. Total revenue for the quarter increased by 2.6% year over year to USD 662.4 million, while net income rose 10.2%, amounting to USD 51.9 million.

Stock Price

On Wednesday, August 2, 2023, ENVISTA HOLDINGS released its Q2 FY2023 financial results, reporting a 0.3 percent dip in stock prices. The stock opened at $33.7 at the beginning of the day and closed at $33.9, lower than the previous closing price of $34. Besides the financial results, ENVISTA HOLDINGS also announced plans to double its research and development budget by the end of 2023. This move is part of the company’s ongoing strategy to invest in emerging technologies and strengthen its position in the market.

Additionally, ENVISTA has also outlined plans to launch three new products by the end of 2023, with an aim to drive further growth and expand its customer base. Overall, ENVISTA HOLDINGS is on track to meet its financial goals for FY2023 and beyond, as it continues to focus on innovation and product development. Investors should keep a close eye on the company’s progress as it looks to strengthen its foothold in the market. Live Quote…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Envista Holdings. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Envista Holdings. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Envista Holdings. More…

Key Ratios Snapshot

Some of the financial key ratios for Envista Holdings are shown below. More…

Analysis – Envista Holdings Intrinsic Value Calculation

We at GoodWhale have completed a comprehensive analysis of ENVISTA HOLDINGS‘ wellbeing. According to our proprietary Valuation Line, the intrinsic value of an ENVISTA HOLDINGS share is around $40.4. This number is in stark contrast to the current trading price of $33.9, representing a 16.1% discount. We believe this makes ENVISTA HOLDINGS a smart investment for those seeking to take advantage of a fair priced stock that is undervalued by the markets. More…

Peers

Its main competitors are Medikit Co Ltd, Nihon Kohden Corp, and Fukuda Denshi Co Ltd. Envista has a strong market presence in the US, Europe, and Asia Pacific.

– Medikit Co Ltd ($TSE:7749)

As of 2022, Medikit Co Ltd has a market cap of 41.17B and a Return on Equity of 6.14%. The company produces and sells medical equipment and supplies. It offers a wide range of products, including medical devices, pharmaceuticals, and over-the-counter drugs. Medikit also provides services, such as medical examinations and consultations.

– Nihon Kohden Corp ($TSE:6849)

Nihon Kohden is a Japanese manufacturer of medical equipment, with a particular focus on patient monitoring systems. The company has a market cap of 278.79B as of 2022 and a return on equity of 13.19%. Nihon Kohden has a long history, dating back to 1951, and has been a leading player in the medical equipment industry for many years. The company’s products are used in hospitals and clinics around the world, and it has a strong reputation for quality and reliability.

– Fukuda Denshi Co Ltd ($TSE:6960)

Fukuda Denshi Co Ltd is a Japanese company that manufactures and sells medical equipment. The company has a market cap of 138.83B as of 2022 and a Return on Equity of 9.95%. Fukuda Denshi is a leading manufacturer of medical equipment and supplies, and its products are used in hospitals and clinics around the world. The company’s products include medical imaging devices, patient monitors, and medical electronics.

Summary

ENVISTA HOLDINGS reported its second quarter FY2023 earnings on August 2 2023, with total revenue of USD 662.4 million, representing a 2.6% year-on-year increase. Net income for the same period increased by 10.2% to USD 51.9 million. This positive performance can be attributed to the company’s cost management strategies and robust product portfolio.

The strong financial results can be seen as an indication of investor confidence in this stock. Investors should carefully monitor any upcoming developments that may impact on ENVISTA HOLDINGS’ future prospects, as well as its competitive position in the market.